@FierceMedDev: AngioDynamics' FY 2013 reflects a partial upswing. Story | Follow @FierceMedDev
@MarkHFierce: Give us your FMD Fierce 15 nominations today - Device and Dx nominations welcome. Submit here | Follow @MarkHFierce
@DamianFierce: AstraZeneca signs up with genomics outfit Blackfield for cancer R&D. More | Follow @DamianFierce
> C.R. Bard ($BCR) got a break late last week when a federal judge declared a mistrial in a product liability lawsuit concerning the company's vaginal mesh devices. A witness' testimony brought on the action. Story
> The FDA has signed off on a new test designed to more quickly determine the effectiveness of steam sterilization for reusable medical devices. Item
> SynGen gained FDA 510(k) clearance for its new system designed to process umbilical cord blood. Item
> Life Technologies ($LIFE) launched the EVOS FL Auto Imaging System, a lab-based cell monitoring device the company said is priced to penetrate emerging markets. More
> A retired cardiovascular surgeon says he's developed a new approach for an artificial pancreas. Story
> Sweden's Episurf Medical won a CE mark for its new personalized knee implant. Item
> Australian researchers are designing an eye implant that would release drugs after a laser targets it. Story
Biotech News
@FierceBiotech: ICYMI last week: The biotech IPO scene turns red hot. Special report | Follow @FierceBiotech
@JohnCFierce: Vivus pushes back shareholder meeting, a sure sign they are losing the fight with FMC. Report | Follow @JohnCFierce
@RyanMFierce: Europe eyes social media and mobile for data on bad drug reactions. Story | Follow @RyanMFierce
@EmilyMFierce: You can't patent human genes. So why are genetic testing companies getting sued? Article | Follow @EmilyMFierce
> Is this the NIH Francis Collins wanted to create? Editor's Corner
> Ipsen bags a development platform with $207M Syntaxin buyout. Story
> Buzz: Why is Roche considering a big buyout of Alexion? Report
Pharma News
@FiercePharma: AstraZeneca CFO jumps ship in latest executive switcheroo. News | Follow @FiercePharma
@EricPFierce: Novartis CEO Jimenez says China is a difficult market, but worth it. I wonder if GSK agrees right now. Article | Follow @EricPFierce
@CarlyHFierce: Here's Vivus' release re: delaying its shareholder meeting - says First Manhattan made false statements. Release | Follow @CarlyHFierce
> Roche may want Alexion, but is the price right? Story
> China calls GSK 'godfather' in alleged bribery scheme. News
CRO News
> Corgenix signs CMO deal with EDP Biotech. Item
> Theorem, Emergo team up for devices and diagnostics. News
> NIH, industry back out of India as trials slow to standstill. Article
> Catalent inks Biota flu deal, shifts delivery biz. Story
Biotech IT News
> Europe eyes social media and mobile for data on bad drug reactions. News
> High-profile VC Sequoia backs clinical tech startup Comprehend in $8.4M round. Story
> Boehringer Ingelheim expands use of Big Data tech for pharma research. Article
> ChemAxon extends pharma software streak with Schrödinger deal. Item